Latin America Advisor published a commentary by Diana Muller on GlaxoSmithKline’s decision to not file patents in some of the world’s poorest countries in order to make it easier for manufacturers in those locations to copy its pharmaceuticals.
Latin America Advisor published a commentary by Diana Muller on GlaxoSmithKline’s decision to not file patents in some of the world’s poorest countries in order to make it easier for manufacturers in those locations to copy its pharmaceuticals.